Veeda Clinical Research

Veeda CR is an independent CRO established in 2004 at Ahmedabad in Gujarat, India. Veeda is one of the top 3 players in the CRO (clinical research organization) industry.

Veeda CR was established with a vision of creating a CRO with in-depth scientific know-how, technical edge and better foresight for clinical trials. The founders’ objective was to become a catalyst for enhanced drug development to facilitate better patient treatments. With more than a decade of experience, Veeda has now become one of the most desired partners to the pharmaceutical fraternity globally for conducting their clinical studies to deliver safe and quality solutions with no compromise on ethical practices.

Today, Veeda CR is an epitome of independence, knowledge, quality, and integrity. These goals were achieved by Veeda CR founders because of their sole-focus on the high-value system, uncompromising ethics and an aptitude for continuous learning for the advancement of science.

Veeda CR is a full-service CRO that conducts clinical research to support clients in their clinical programs. The company provides expert services in PK (pharmacokinetic) and PD (pharmacodynamics) studies in healthy volunteers; conducts patient trials in generic molecules and NCEs (new chemical entity) and undertakes research in Biopharmaceuticals. The company offers a fully integrated package which includes services on Phase I to Phase IV clinical trials in the central nervous system, oncology, and other complex therapeutic areas. The company’s services also include clinical trial management services comprising patient recruitment and retention, project management, clinical monitoring, drug safety/pharmacovigilance, medical affairs, quality assurance, and regulatory and medical writing to meet global clinical development needs.

Veeda CR was the first Indian CRO company to have entered into a strategic contract with MNCs and large Indian Pharma companies. Currently, Veeda is working with 10 of the top 15 Global Pharmaceutical companies. As of 2016-17, the company derived 38% of its revenues from India, 21% from the US, 29% from EU and 12% from the rest of the world.

Veeda’s Expert Services:-

• BA/BE Studies

• Central Bioanalytical Services

• First-in-Man Studies

• Drug Interaction Studies

• Glucose Clamp Studies

• Patient PK Studies

• Clinical Trials

• Inhalation Studies

• PD Endpoint studies

• Complex Bioanalysis (Vitamins etc.)

• Elemental Bioanalysis

• Pharmacovigilance Services